BRPI0718437A2 - Métodos e terapias de combinação para tratar a doença de alzheimer usando, entre outros, dimebon e dolepezil - Google Patents
Métodos e terapias de combinação para tratar a doença de alzheimer usando, entre outros, dimebon e dolepezilInfo
- Publication number
- BRPI0718437A2 BRPI0718437A2 BRPI0718437-9A2A BRPI0718437A BRPI0718437A2 BR PI0718437 A2 BRPI0718437 A2 BR PI0718437A2 BR PI0718437 A BRPI0718437 A BR PI0718437A BR PI0718437 A2 BRPI0718437 A2 BR PI0718437A2
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- dimebon
- therapies
- dolepezil
- treat alzheimer
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 3
- JNODQFNWMXFMEV-UHFFFAOYSA-N latrepirdine Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1 JNODQFNWMXFMEV-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- RDMFHRSPDKWERA-UHFFFAOYSA-N 5H-Pyrido[4,3-b]indole Chemical class C1=NC=C2C3=CC=CC=C3NC2=C1 RDMFHRSPDKWERA-UHFFFAOYSA-N 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85486606P | 2006-10-27 | 2006-10-27 | |
| PCT/US2007/022645 WO2008051599A2 (en) | 2006-10-27 | 2007-10-26 | Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0718437A2 true BRPI0718437A2 (pt) | 2013-11-19 |
Family
ID=39315586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0718437-9A2A BRPI0718437A2 (pt) | 2006-10-27 | 2007-10-26 | Métodos e terapias de combinação para tratar a doença de alzheimer usando, entre outros, dimebon e dolepezil |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100152108A1 (pt) |
| EP (2) | EP2420235A1 (pt) |
| JP (1) | JP2010507672A (pt) |
| KR (1) | KR20090087009A (pt) |
| CN (1) | CN101631547A (pt) |
| AT (1) | ATE549021T1 (pt) |
| AU (1) | AU2007309390A1 (pt) |
| BR (1) | BRPI0718437A2 (pt) |
| CA (1) | CA2667553A1 (pt) |
| IL (2) | IL198405A0 (pt) |
| MX (1) | MX2009004516A (pt) |
| NO (1) | NO20092051L (pt) |
| RU (1) | RU2009120048A (pt) |
| SG (1) | SG178000A1 (pt) |
| WO (1) | WO2008051599A2 (pt) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| RU2334514C1 (ru) * | 2006-12-01 | 2008-09-27 | Институт физиологически активных веществ Российской Академии наук | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| US8541437B2 (en) * | 2007-04-05 | 2013-09-24 | Alla Chem, Llc | Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof |
| AU2008302751A1 (en) | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
| RU2544856C2 (ru) | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| TWI443098B (zh) | 2008-03-24 | 2014-07-01 | Medivation Technologies Inc | 吡啶并〔３，４－ｂ〕吲哚及使用方法 |
| TWI450900B (zh) | 2008-03-24 | 2014-09-01 | Medivation Technologies Inc | 橋聯雜環化合物及使用方法 |
| WO2010031054A1 (en) | 2008-09-15 | 2010-03-18 | Biovista, Inc. | Compositions and methods for treating epilepsy |
| TW201018694A (en) | 2008-09-29 | 2010-05-16 | Abbott Lab | Indole and indoline derivatives and methods of use thereof |
| US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| AR073923A1 (es) | 2008-10-31 | 2010-12-09 | Medivation Technologies Inc | Pirido( 4,3-b) indoles que contienen restos rigidos |
| CN102316732B (zh) | 2008-10-31 | 2015-04-01 | 梅迪维新技术公司 | 氮杂*并[4,5-b]吲哚以及使用方法 |
| US20100125085A1 (en) * | 2008-11-17 | 2010-05-20 | Auspex Pharmaceuticals, Inc. | Pyridoindole modulators of nmda receptor and acetylcholinesterase |
| EP2381955A4 (en) * | 2008-12-30 | 2013-01-16 | Univ Ramot | COMBINATION THERAPIES WITH NAP |
| AU2010214101A1 (en) | 2009-02-11 | 2011-09-01 | Sunovion Pharmaceuticals Inc. | Histamine H3 inverse agonists and antagonists and methods of use thereof |
| CN102395369A (zh) * | 2009-04-10 | 2012-03-28 | 中国人民解放军军事医学科学院毒物药物研究所 | 含有四氢吡啶[4，3-b]吲哚衍生物的缓释组合物及该衍生物的制备方法 |
| WO2010127177A1 (en) * | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
| WO2011019417A1 (en) | 2009-04-29 | 2011-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b] indoles and methods of use |
| JP2013504580A (ja) * | 2009-09-11 | 2013-02-07 | スノヴィオン ファーマシューティカルズ インコーポレイテッド | ヒスタミンｈ３インバースアゴニストおよびアンタゴニストとその使用方法 |
| AU2010298168B2 (en) | 2009-09-23 | 2015-11-19 | Medivation Technologies, Inc. | Pyrido(3,4-b)indoles and methods of use |
| WO2011038161A1 (en) | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles and methods of use |
| CN102711466A (zh) | 2009-09-23 | 2012-10-03 | 梅迪维新技术公司 | 桥连杂环化合物及其使用方法 |
| WO2011039675A2 (en) * | 2009-09-30 | 2011-04-07 | Pfizer Inc. | Latrepirdine transdermal therapeutic dosage forms |
| RU2425046C1 (ru) * | 2009-12-04 | 2011-07-27 | Сергей Олегович Бачурин | АНТИДЕПРЕССИВНОЕ И ПРОТИВОГИПОКСИЧЕСКОЕ СРЕДСТВО НА ОСНОВЕ СОЛЕЙ 2,8-ДИМЕТИЛ-5-[2-(6-МЕТИЛ-ПИРИДИЛ-3)ЭТИЛ]-2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛА И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ |
| EP2533645B1 (en) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| TR201001117A1 (tr) * | 2010-02-15 | 2011-09-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Dimebolin ve memantin kombinasyonları |
| US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9034865B2 (en) | 2010-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9187471B2 (en) | 2010-02-19 | 2015-11-17 | Medivation Technologies, Inc. | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| WO2012016708A1 (en) * | 2010-08-06 | 2012-02-09 | Ratiopharm Gmbh | Oral dosage form comprising dimebolin and donepezil |
| EP2619205B1 (en) | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
| US20140155384A1 (en) | 2011-02-18 | 2014-06-05 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| CA2829045A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| WO2012112964A2 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE |
| WO2012112965A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| WO2012122405A2 (en) * | 2011-03-08 | 2012-09-13 | The Trustees Of Columbia University In The City Of New York | Screening assays using stem cells and stem cell-derived neurons from mouse models of alzheimer's disease |
| DE102012003065A1 (de) * | 2012-02-13 | 2013-08-14 | Friedrich-Schiller-Universität Jena | Neue bivalente Gammacarbolinderivate sowie deren Herstellung und Verwendung als Antidementiva |
| WO2013130422A1 (en) | 2012-02-27 | 2013-09-06 | Biovista, Inc. | Compositions and methods for treating mitochondrial diseases |
| RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
| CN104582796A (zh) * | 2012-06-27 | 2015-04-29 | 迈阿密大学 | 治疗阿尔茨海默病的组合物和方法 |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| RU2496465C1 (ru) * | 2012-11-15 | 2013-10-27 | Борис Николаевич Анисимов | Способ профилактики развития и прогрессирования болезни альцгеймера на курортном этапе |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| WO2016179217A1 (en) * | 2015-05-06 | 2016-11-10 | Ohio University | Metal ion chelation for enhancing the effect of tissue plasminogen activator (tpa) in thromobolysis |
| EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US10639315B1 (en) | 2019-05-21 | 2020-05-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating Alzheimer's disease |
| US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
| US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
| US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
| US10898493B2 (en) | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
| US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
| US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
| US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
| US11938139B2 (en) | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
| KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
| EP3973586A4 (en) * | 2019-05-21 | 2023-01-11 | La Pharma Tech Inc. | NEW PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF MENTAL, BEHAVIORAL AND COGNITIVE DISORDERS |
| IL297861A (en) | 2020-05-08 | 2023-01-01 | Psilera Inc | Novel compositions of matter and pharmaceutical compositions |
| BR112022025306A2 (pt) * | 2020-06-12 | 2023-02-28 | Beckley Psytech Ltd | Composição compreendendo um sal benzoato de 5-metóxin, n-dimetiltriptamina |
| EP4297871A4 (en) * | 2021-02-26 | 2025-01-01 | BioXcel Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR TREATING AGITATION |
| US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
| DK4452267T3 (da) * | 2021-12-23 | 2025-05-26 | Cilcare Dev | 4-phenyl-tetrahydropyridinderivater til behandling af hørelidelser |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR8204M (pt) | 1967-12-08 | 1970-09-14 | ||
| DE1952800C3 (de) | 1969-10-20 | 1974-04-18 | Nautschno-Issledowatelskij Institut Farmakologii I Chimioterapii, Moskau | 3,6-Dimethyl-l,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid |
| US3718657A (en) | 1970-12-03 | 1973-02-27 | Abbott Lab | Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines |
| IL74497A (en) | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| DE10299048I2 (de) | 1989-04-14 | 2006-07-13 | Merz Pharma Gmbh & Co Kgaa | Verwendung von Adamantan-Derivaten zur Pr{vention und Behandlung der cerebralen Isch{mie |
| US5614560A (en) | 1991-04-04 | 1997-03-25 | Children's Medical Center Corporation | Method of preventing NMDA receptor-mediated neuronal damage |
| RU2106864C1 (ru) * | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
| WO1997046526A1 (en) | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
| TW513409B (en) | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
| TW506836B (en) | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
| JPH10259126A (ja) * | 1997-01-17 | 1998-09-29 | Takeda Chem Ind Ltd | アルツハイマー病治療・予防剤 |
| WO1999029668A1 (en) | 1997-12-05 | 1999-06-17 | Eisai Co., Ltd. | Donepezil polycrystals and process for producing the same |
| US6372760B1 (en) | 1999-03-31 | 2002-04-16 | Eisai Co., Ltd. | Stabilized composition comprising antidementia medicament |
| AU2003279216A1 (en) | 2002-10-09 | 2004-05-04 | Rinat Neuroscience Corp. | Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| CN100339070C (zh) * | 2002-10-24 | 2007-09-26 | 莫茨药物股份两合公司 | 包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物 |
| BRPI0411451A (pt) * | 2003-06-16 | 2006-07-18 | Allergan Inc | formas de dosagens orais de memantina |
| RU2283108C2 (ru) | 2003-12-08 | 2006-09-10 | Сергей Олегович Бачурин | ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| JP5180816B2 (ja) * | 2005-04-04 | 2013-04-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 神経変性疾患および認知症のためのジヒドロピリジン化合物 |
-
2007
- 2007-10-26 EP EP11181674A patent/EP2420235A1/en not_active Withdrawn
- 2007-10-26 US US12/447,448 patent/US20100152108A1/en not_active Abandoned
- 2007-10-26 AT AT07867284T patent/ATE549021T1/de active
- 2007-10-26 BR BRPI0718437-9A2A patent/BRPI0718437A2/pt not_active Application Discontinuation
- 2007-10-26 KR KR1020097010803A patent/KR20090087009A/ko not_active Withdrawn
- 2007-10-26 MX MX2009004516A patent/MX2009004516A/es not_active Application Discontinuation
- 2007-10-26 RU RU2009120048/15A patent/RU2009120048A/ru not_active Application Discontinuation
- 2007-10-26 EP EP07867284A patent/EP2086538B1/en not_active Not-in-force
- 2007-10-26 AU AU2007309390A patent/AU2007309390A1/en not_active Abandoned
- 2007-10-26 CN CN200780048266A patent/CN101631547A/zh active Pending
- 2007-10-26 CA CA002667553A patent/CA2667553A1/en not_active Abandoned
- 2007-10-26 JP JP2009534657A patent/JP2010507672A/ja active Pending
- 2007-10-26 SG SG2012004289A patent/SG178000A1/en unknown
- 2007-10-26 WO PCT/US2007/022645 patent/WO2008051599A2/en not_active Ceased
-
2009
- 2009-04-26 IL IL198405A patent/IL198405A0/en unknown
- 2009-05-26 NO NO20092051A patent/NO20092051L/no not_active Application Discontinuation
-
2012
- 2012-05-10 IL IL219709A patent/IL219709A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE549021T1 (de) | 2012-03-15 |
| RU2009120048A (ru) | 2010-12-10 |
| AU2007309390A1 (en) | 2008-05-02 |
| JP2010507672A (ja) | 2010-03-11 |
| US20100152108A1 (en) | 2010-06-17 |
| IL198405A0 (en) | 2010-02-17 |
| IL219709A0 (en) | 2012-06-28 |
| EP2086538B1 (en) | 2012-03-14 |
| NO20092051L (no) | 2009-07-22 |
| WO2008051599A3 (en) | 2008-07-24 |
| EP2086538A2 (en) | 2009-08-12 |
| SG178000A1 (en) | 2012-02-28 |
| CN101631547A (zh) | 2010-01-20 |
| EP2420235A1 (en) | 2012-02-22 |
| CA2667553A1 (en) | 2008-05-02 |
| WO2008051599A2 (en) | 2008-05-02 |
| KR20090087009A (ko) | 2009-08-14 |
| MX2009004516A (es) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL219709A0 (en) | Method and combination therapies for treating alzheimer's disease | |
| CL2008001932A1 (es) | Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer. | |
| MX2010001218A (es) | Metodos y composiciones para tratamiento contra esquizofrenia mediante uso de terapia combinada de agentes antipsicoticos. | |
| EA200801551A1 (ru) | Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы | |
| WO2007041697A3 (en) | Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| GB2442915B (en) | Perylenequinone derivatives and uses thereof | |
| ATE538103T1 (de) | Chinazolinonverbindungen als antikrebsmittel | |
| TW200722083A (en) | Combinations and methods of using an indolinone compound | |
| MX2009010066A (es) | Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer. | |
| GT200900283A (es) | "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario". | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| ATE407927T1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
| WO2006102370A3 (en) | Functional brain mri mapping as a marker in cns diseases and disorders | |
| EP2101578A4 (en) | MEANS FOR THE TREATMENT OF ACUTE AND CHRONIC DISORDERS OF CEREBRAL CIRCULATION, INCLUDING BRAIN ACTIVATING, BASED ON HYDROGENATED PYRIDOÝ4,3-BINDERS (VARIANTS), PHARMACOLOGICAL MEANS BASED THEREON, AND METHODS FOR THE USE OF THEM | |
| NO20080969L (no) | 1,2-diarylimidazoler for anvendelse som CBI-modulatorer | |
| WO2006047032A3 (en) | Indole compounds useful as serotonin selective agents | |
| UA95103C2 (ru) | Замещенные арилсульфонамиды в качестве противовирусных средств | |
| ECSP088250A (es) | Derivados de pirazol como agentes terapéuticos | |
| GB0416508D0 (en) | Therapeutic agents | |
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| NO20063368L (no) | Alfa-aminoamid-derivater anvendelige ved behandling av lidelser i nedre urinveier | |
| PT1899334E (pt) | Compostos de naftiridina | |
| BRPI0807867A2 (pt) | Derivado de indol ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um derivado de (indol-3-il) heterociclo, e, método de tratamento de dor | |
| BR0313588A (pt) | Métodos para o tratamento da demência com base em apo e genótipo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |